TY - JOUR
T1 - First clinical study of the novel platelet ADP receptor (P-2 gamma) antagonist AR-C69931MX, assessing safety, tolerability and activity in patients with acute coronary syndromes
JO - CIRCULATION
PY - 1999/11/02
AU - Storey RF
AU - Oldroyd KG
AU - Wilcox RG
ED -
VL - 100
IS - 18
SP - 710
EP - 710
Y2 - 2025/07/13
ER -